Literature DB >> 25354500

Overweight and grade I obesity in patients with cardiovascular disease: to treat or not to treat?

Maciej Haberka, Katarzyna Stolarz-Skrzypek, Danuta Czarnecka, Zbigniew Gąsior, Magdalena Olszanecka-Glinianowicz.   

Abstract

Obesity is a significant public health problem, associated with several comorbidities and complications. At the same time, the results of studies suggest that the relationship between obesity and survival in subjects diagnosed with cardiovascular disease is a U-shaped curve with a significantly worse prognosis among underweight and morbidly obese individuals. The association between overweight or grade I obesity and cardiovascular mortality is not clear, and numerous studies have shown an unexpected and paradoxical inverse relationship with better prognosis in this patient group, the so-called "obesity paradox". In the current review, we discuss the most important and most reliable studies regarding the prognosis and clinical course in patients with overweight or grade I obesity and essential hypertension, coronary artery disease, or heart failure, focusing on data for and against the obesity paradox.

Entities:  

Mesh:

Year:  2014        PMID: 25354500     DOI: 10.20452/pamw.2564

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  2 in total

1.  Effects of administration of omega-3 fatty acids with or without vitamin E supplementation on adiponectin gene expression in PBMCs and serum adiponectin and adipocyte fatty acid-binding protein levels in male patients with CAD.

Authors:  Magdalena Mostowik; Grzegorz Gajos
Journal:  Anatol J Cardiol       Date:  2016-10       Impact factor: 1.596

2.  The obesity paradox in the stress echo lab: fat is better for hearts with ischemia or coronary microvascular dysfunction.

Authors:  Lauro Cortigiani; Maciej Haberka; Quirino Ciampi; Francesco Bovenzi; Bruno Villari; Eugenio Picano
Journal:  Int J Obes (Lond)       Date:  2020-08-24       Impact factor: 5.095

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.